Mankind Pharma Ltd share price logo

Mankind Pharma Ltd Share Price

(MANKIND)

Large Cap

Healthcare Sector

Check the latest share price of Mankind Pharma Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹2556.9

▲0.14%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Mankind Pharma Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹2,539.9
    Day's Price Range
    ₹2,598.5

  • 52 Week's Low

    52 Week's High

    ₹1,901.05
    52-Week Price Range
    ₹3,054.8
1 Month Return+ 8.27 %
3 Month Return-9.46 %
1 Year Return+ 3.67 %
Previous Close₹2,560.40
Open₹2,560.40
Volume1.05L
Upper Circuit-
Lower Circuit-
Market Cap₹96,976.58Cr

Mankind Pharma Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹87,426.64 Cr

Return on Equity (ROE)

8.43

Return on capital employed (ROCE)

9.84

P/B Ratio

2.7

Dividend Yield

0.72

EPS (TTM)

44.65

Sector

Pharmaceuticals

How to invest in Mankind Pharma Ltd

Investing in Mankind Pharma Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Mankind Pharma Ltd or MANKIND on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Mankind Pharma Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Mankind Pharma Ltd with just a few clicks!

Mankind Pharma Ltd Valuation

Track how the P/E of Mankind Pharma Ltd has moved over time to understand valuation trends.

Mankind Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (41.33x)

May 24, 2023

Today (48.69x)

December 15, 2023

Industry (58.33x)

December 15, 2023

Highest (54.59x)

June 20, 2023

LowHigh

Today’s Price to Earnings Ratio: 48.69x

Analysts Recommendation on Mankind Pharma Ltd

Get updated buy, sell, and hold recommendations by analysts on Mankind Pharma Ltd.

based on 11 analysts

BUY

54.55%

Buy

27.27%

Hold

18.18%

Sell

54.55% of analysts recommend a 'BUY' rating for Mankind Pharma Ltd. Average target of ₹1863.27

Source: S&P Global Market Intelligence

Analysts Forecast on Mankind Pharma Ltd

Get share price movements and forecasts by analysts on Mankind Pharma Ltd.

Mankind Pharma Ltd price forecast by 11 analysts

Downside of-20.73%

High

₹2190

Target

₹1863.27

Low

₹1433

Mankind Pharma Ltd target price ₹1863.27, a slight downside of -20.73% compared to current price of ₹2556.9. According to 11 analysts rating.

Source: S&P Global Market Intelligence

Mankind Pharma Ltd Index Inclusions

BSE 200

₹10,982.20

0 (▲0%)

S&P BSE Largecap

₹9,352.02

0 (▲0%)

BSE 500

₹34,765.79

0 (▲0%)

S&P BSE 100 LargeCap TMC

₹8,972.67

0 (▲0%)

NIFTY PHARMA

₹21,676.65

-1.06 (▲-231.45%)

Nifty 500

₹0.00

0 (▲0%)

Nifty Midcap 100

₹54,587.95

0.27 (▲147.7%)

Nifty 200

₹13,469.00

0.03 (▲4.4%)

BSE Healthcare

₹42,555.65

0 (▲0%)

Nifty LargeMidcap 250

₹15,416.05

0.1 (▲15.35%)

S&P BSE 250 LargeMidCap

₹10,383.27

0 (▲0%)

Nifty Healthcare

₹13,992.20

-0.88 (▲-124.05%)

Nifty Midcap 150

₹20,009.05

0.21 (▲42.35%)

Nifty MidSmallcap 400

₹18,431.30

0.21 (▲38.8%)

S&P BSE AllCap

₹10,471.31

0 (▲0%)

Mankind Pharma Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Mankind Pharma Ltd with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
BUY₹87,426.64 Cr31.24%0.59NANA
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd
BUY₹1,05,894.82 Cr34.5%0.68NANA
Cipla Ltd
Cipla Ltd
BUY₹1,18,158.42 Cr29.4%0.50NANA
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
BUY₹4,04,899.77 Cr55.14%0.60NANA
Lupin Ltd
Lupin Ltd
HOLD₹89,909.07 Cr28.6%0.53NANA
See all

Mankind Pharma Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Mankind Pharma Ltd.

  • Mankind Pharma Plans Integration of Bharat Serums - 14 Apr, 2025

    Mankind Pharma's board has approved the formation of a committee to explore structural integration options for Bharat Serums and Vaccines (BSV), following last year's acquisition deal.

  • NCLT Approves Amalgamation for Mankind Pharma Subsidiary - 01 Apr, 2025

    The National Company Law Tribunal approved the amalgamation of BSV Pharma, a subsidiary of Mankind Pharma, with Bharat Serums and Vaccines, effective May 9, 2022.

  • Mankind Pharma Completes Subsidiary Amalgamation Successfully - 29 Mar, 2025

    Mankind Pharma has successfully completed the amalgamation of three subsidiaries—Shree Jee Laboratory, JPR Labs, and Jaspack Industries—effective March 29, 2025, following NCLT approval. The merger aims to streamline operations and enhance synergy, with the authorized share capital adjusted to Rs 421.51 crore.

  • Mankind Pharma Faces ₹183 Crore Tax Demand - 28 Mar, 2025

    Mankind Pharma has received a ₹183 crore tax demand from the Income Tax Department for AY 2014-15 to 2017-18. The company plans to appeal, asserting the demand is unjustified and will not materially impact its operations.

  • Mankind Pharma Shares Surge Amid FTSE Rebalancing - 21 Mar, 2025

    Mankind Pharma shares experienced a significant rise as the FTSE's March semi-annual rebalancing came into effect, contributing to increased trading volumes.

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 2.53K Cr → 3.31K Cr (in ₹), with an average increase of 8.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, MANKIND stock has moved up by 3.4%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 2.90% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 653.47 Cr → 380.23 Cr (in ₹), with an average decrease of 41.8% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 13.34% to 12.92% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 7.83% to 7.67% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.71% to 72.70% in Mar 2025 quarter

About Mankind Pharma Ltd

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Revenue: ₹2,893.42Cr as on June 2024 (Q2 24)
Net Profit: ₹543.07Cr as on June 2024 (Q2 24)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Indian Mutual Funds that own Mankind Pharma Ltd

Check out the Mutual Funds with significant holdings in Mankind Pharma Ltd.

Futures and Options

View the latest movement in Mankind Pharma Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is Mankind Pharma Ltd price today?

Mankind Pharma Ltd share price today stands at ₹2556.9, Open: ₹2560.4, Previous Close: ₹2560.4, High: ₹2598.5, Low: ₹2539.9, 52 Week High: ₹3054.8, 52 Week Low: ₹1901.05.

How to Buy Mankind Pharma Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Mankind Pharma Ltd shares

What are today's traded volumes of Mankind Pharma Ltd?

Today's traded volume of Mankind Pharma Ltd(MANKIND) is 1.05L.

What is today's market capitalisation of Mankind Pharma Ltd?

Today's market capitalisation of Mankind Pharma Ltd(MANKIND) is ₹96,976.58 Cr.

What is the 52 Week High and Low Range of Mankind Pharma Ltd?

Mankind Pharma Ltd (MANKIND)
Price
52 Week High
₹3054.8
52 Week Low
₹1901.05

How much percentage Mankind Pharma Ltd is down from its 52 Week High?

Mankind Pharma Ltd (MANKIND) share price is ₹2556.9. It is down -16.30% from its 52 Week High price of ₹3054.8

How much percentage Mankind Pharma Ltd is up from its 52 Week low?

Mankind Pharma Ltd (MANKIND) share price is ₹2556.9. It is up 34.50% from its 52 Week Low price of ₹1901.05